Home » Tender for The Dak-gesundheit Intends To Conclude A Non-exclusive Discount Agreement For The Active Ingredient Ganirelix, Atc H01cc01, For The Period From June 1, 2026, To May 31, 2028, With An Option For A 12-month Extension. This Agreement Is Based On § 130a Abs., Germany